Globus Medical, Inc. (BMV:GMED)

Market Cap	136.37B
Revenue (ttm)	51.32B
Net Income (ttm)	3.79B
Shares Out	n/a
EPS (ttm)	27.30
PE Ratio	35.96
Forward PE	15.99
Dividend	n/a
Ex-Dividend Date	n/a

Volume	60
Average Volume	1,207
Open	991.50
Previous Close	1,050.00
Day's Range	991.50 - 991.50
52-Week Range	991.50 - 1,888.19
Beta	n/a
RSI	38.80
Earnings Date	Aug 5, 2025

About Exscientia

Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers musculoskeletal solutions, including spine products, such as traditional fusion implants, and treatment options for motion preservation technologies, and interventional solutions to treat vertebral compression fractures; orthopedic trauma solutions, which includes fracture plating, intramedullary nailing, and regenerative biologic products; hip a...

• Industry: Surgical and Medical Instruments and Apparatus
• Founded: 2003
• Employees: 5,300
• Stock Exchange: Mexican Stock Exchange
• Ticker Symbol: GMED

Financial Performance

In 2024, Globus Medical's revenue was $2.52 billion, an increase of 60.62% compared to the previous year's $1.57 billion. Earnings were $102.98 million, a decrease of -16.19%.

Financial numbers in EUR